Drug Interactions Involving the Drugs of Abuse

Adams H. R. Dixit B. N. : Prolongation of Pentobarbital Anesthesia by CPZ in Dogs and Cats, J. Amer. Veterinary Med. Assoc. 156: 902–905, 1970.

Aggeler P. O'Reilly R. A. : The Effects of Heptobarbitol on the Response to Bishvdroxycoumarin in Man, J. Lab. Clin. Med. 74: 229–238, 1969.

Anonymous: Pethidine Poisoning, British Med. J. 2: 822 (Oct.) 1963.

Arnfred T. Randrup A. : Cholinergic Mechanism in Brain-Inhibiting Amphetamine and Induced Stereotype Behavior, Acta Pharmacol. Toxicol. 26: 384–394, 1968.

Asatoor A. London D. Milne M. Simehoff M. : The Excretion of Pethidine and Its Derivatives, Brit. J. Pharmacol. 20: 285, 1963.

Asatoor A. M. Galman B. R. Johnson J. R. Milne M. D. : The Excretion of Dextroamphetamine and Its Derivatives, Brit. J. Pharmacol. 24: 293–300, 1965.

Axelrod J. : Studies on Sympathomimetic Amines II. The Biotransformation and Physiological Disposition of d-Amphetamine, d-p-Hydroxyamphetamine and d-Methamphetamine. J. Pharmacol. Exp. Ther. 110: 315–326, 1954a.

Axelrod J. : An Enzyme for the Deamination of Sympthomimetic Amines: Properties and Distribution, J. Pharmacol. Exp. Ther. 110: 2–7, 1954b.

Axelrod J. : The Enzymatic Deamination of Amphetamine (Benzedrine), J. Biol. Chem. 214: 753–756, 1955.

Beckett A. H. Rowland M. Turner P. : Influence of Urinary pH on Excretion of Amphetamine, Lancet 1: 303, 1965.

Beckett A. H. Tucker G. T. : Application of the Analogue Computer Pharmacokinetic and Biopharmaceutical Studies with Amphetamine-type Compounds, J. Pharm. and Pharmacology, 20: 174–193, 1968.

Beckett A. H. Brookes L. G. Shenoy E. V. Urinary Excretion of the Drug and its Main Metabolites in Man after the Administration of (plus or minus), (plus) and (minus) Ethylamphetamine, J. Pharm. Pharmacol. 21: Supp: 1515, 1969.

Bekadorff S. : Tranylcypromine Cepalgea, Can. Med. Assoc. J. 90: 381–382, 1964.

Bellville J. W. Forrest W. H. Jr. Shroff P. Brown B. W. : Prolongation of Pentobarbital Anesthesia by Chloramphenicol in Dogs and Cats, Clin. Pharmacol. Ther. 12: 607–612, 1971.

Bethune H. C. Burrell R. H. Culpan R. H. : Headache Associated with Monoamine Oxidase Inhibitors, Lancet 2: 1233, 1963.

Borella L. E. : Effect of Chlorpromazine on the Urinary Excretion of Amphetamine in Rats, Pharmacologist 11: 292, 1969.

Boston Collaborative Drug Surveillance Program: Interaction Between Chloral Hydrate and Warfarin, N. Engl. J. Med. 286: 53–55, 1972.

Brodie B. B. Cho A. K. Stefano F. T. E. Gessa G. L. : On Mechanisms of Norepinephrine Release by Amphetamine and Tyramine and Tolerance to Their Effects, in: Costa E. Greengard D. , eds. Advances in Biochemical Pharmacology, Raven Press, New York, 1969.

Brodie B. B. Cho A. K. Gesse G. L. : Possible Role of p-Hydroxynorepinephrine in the Depletion of Norepinephrine Induced by d-Amphetamine and in Tolerance to this Drug, in: Costa E. Garaltini S. , eds. Amphetamine and Related Compounds; Proceedings of the Mario Negri Institute For Pharmacological Research, Milan, Italy. Raven Press, New York, 1970.

Brownlee G. Williams G. W. : Potentiation of Amphetamine and Pethidine by Monoamine Oxidase Inhibitors, Lancet 1: 1323, March, 1963.

Bulla J. Ewing J. A. Buffaloe W. J. : Further Controlled Studies of Meprobamate, Amer. Practitioners 10: 1961, 1959.

Burns J. J. , Role of Biotransformation, in: Papperen R. Kitz L. , eds. Uptake and Distribution of Anesthetic Agents, McGraw-Hill and Company, New York, 1963.

Busfield D. Child K. J. Atkinson R. M. Tomich E. G. : An Effect of Phenobarbitone on Blood Levels of Griseofulvin in Man, Lancet, 2: 1042–1043, 1963.

Busfield D. Child K. J. Tomich E. G. : An Effect of Phenobarbitone on Griseofulvin Metabolism in the Rat, Brit. J. Pharmacol. 22: 137, 1964.

Buxbaum D. M. Sanders-Bush E. Efron D. H. : Analgesic Activity of Δ⁹-Tetrahydrocannabinol (THC) in the Rat and Mouse, Fed. Proc. 28: 735, 1969.

Cahn C. H. : Intoxication by Ethchlorvynol, Can. Med. Assoc. J. 81: 733, 1959.

Carlsson A. Lindquist M. : Central and Peripheral Monoamine Membrane Pump Blockage by Some Addictive Analgesics and Antihistamine. J. Pharm. Pharmacol. 21: 460–464, 1969.

Carlton P. L. : Cholinergic Mechanisms in the Control of Behavior by the Brain, Psychol. Rev. 70: 19–39, 1963.

Canavaugh J. H. Griffith J. D. Oates J. A. : The Effect of Acute and Chronic Amphetamine Administration of the Adrenergic Neuron of Man, in: Costa E. Garaltini S. , eds. Amphetamine and Related Compounds: Proceedings of the Maria Negri Institute For Pharmacological Research, Milan, Italy, Raven Press, New York, 1970.

Clement A. Benazon D. : Reaction to Other Drugs in Patients Taking Monoamine Oxidase Inhibitors. Lancet 2: 197–198, 1962.

Coates G. L. Brickman G. L. Meade G. M. : Toxicity of Isonicotinic Acid Hydrazides in Pulmonary Tuberculosis, Arch. Intern. Med. 93: 541–549, 1954.

Cocks D. Passmore-Rowe A. : Dangers of Monoamine Oxidase Inhibitors, Brit. Med. J. 2: 1545–46, 1962.

Conney A. H. : Pharmacological Implications of Microsomal Enzyme Induction, Pharmacol. Rev. 19: 317–366, 1966.

Consolo S. Dolfini E. Garattini S. Valzelli L. : Desipramine and Amphetamine Metabolism, J. Pharm. Pharmacol. 19: 253–256, 1967.

Cooper A. J. Magnes R. V. Rose M. : A Hypertensive Syndrome with Tranylcypromine Medication, Lancet 1: 527–529, 1964.

Coper H. Lison H. Rommelspachero H. Schulze G. Strauss S. : The Influence of Adrenergic Receptor Blocking Agents Amphetamine and 6-aminonicotinamide on Thermoregulation, Arch. Pharmacol. Nannym-Schmiedebergs 270: 378–391, 1971.

Crawford L. S. Rudofsky I. S. : Some Alterations in the Pattern of Drug Metabolism Associated with Pregnancy, Oral Contraceptives, and the Newly-Born, Brit. J. Anesth. 38: 446, 1966.

Cucinell S. A. Conney A. H. Sansur M. S. Burns J. J. : Lowering Effect of Phenobarbital on Plasma Levels of Bishydroxycoumarin (Dicumarol) and Diphenylhydantoin (Dilantin), Clin. Pharmacol. Ther. 6: 420, 1965.

Cucinelli S. A. Olessky L. Weiss M. Dayton P. G. : The Effect of Chloral Hydrate on Bishydroxycoumarin Metabolism, a Total of Time, J. Amer. Med. Assoc. 197: 366–368, 1966.

Curry S. H. Davis J. M. Janowsky D. S. Marshall J. H. : Factors Affecting Chlorpromazine Levels in Psychiatric Patients, Arch. Gen. Psych. 22: 209–215, 1970.

Dagermanieau R. Hodge H. : Are Biogenic Amines Involved in the Mechanism of Action of Tetrahydrocannabinol's, Agents and Action 1: 6, 1970.

Dally P. J. : Fatal Reaction Associated with Tranylcypromine and Methamphetamine, Lancet 1: 1235–36, 1962.

Davis J. M. Fann W. E. Griffith J. Lemberger L. : Pharmacological Aspects of the Treatment of Amphetamine Abuse: The Effects of Urinary pH, in: Vinar O. Volava Z. Bradley P. B. , eds. Advances in Neuropsychopharmacology, North Holland Publishing Company, Amsterdam, 1971a.

Davis J. M. Koplin I. J. Lemberger L. Axelrod J. : Effects of Urinary pH on Amphetamine Metabolism, Ann. N.Y. Acad. Sci. 179: 493–501, 1971b.

Denton P. H. Borrelli V. Edwards N. : Dangers of Monoamine Oxidase Inhibitors, Brit. Med. J. 2: 1752–53, 1962.

Deshmankar B. S. Lewis J. A. : Ventricular Tachycardia Associated with the Administration of Methylphenidate during Guanethidine Therapy, Can. Med. Assoc. J. 97: 1166–1167, November, 1967.

Dolfeni E. Valzelli L. Garattini S. : Further Studies on Interaction Between Desipramine and Amphetamine, Eur. J. Pharmacol. 5: 185–190, 1969.

Dorrell W. : Tranylcypromine and Intracranical Bleeding, Lancet 2: 414, 1963.

Dring L. G. Smith R. L. Williams R. T. : The Fate of Amphetamines in Man and Other Mammals, J. Pharm. Pharmacol. 18: 402–405, 1966.

Drink L. G. Smith R. L. Williams R. T. : The Metabolic Fate of Amphetamines in Man and Other Species, Biochem. J. 112: 425–435, 1970.

Dundee J. : Thiopentone and Other Thiobarbiturates, Livingston, Edinburgh and London, 1956, P. 123.

Eaden N. R. Renton K. W. : The Effect of Phenelzine and Tranylcypromine on the Degradation of Meperidine, J. Pharmacol. Exp. Ther. 173: 31–36, 1970.

Eddy N. R. Halbach H. Isbell H. Seevers M. H. : Drug Dependency, Its Significance and Characteristics, Psychopharmacol. Bull. 3: 3, 1966.

Ellinwood E. H. Ewing J. A. Hoaken P. C. S. : Habituation to Ethinamate, N. Engl. J. Med. 266: 185–186, 1962.

El-Yousef M. K. Janowsky D. S. Davis J. M. Rosenblatt J. E. : Induction of Severe Depression by Physostigmine in Marijuana Intoxicated Individuals, Brit. J. Addict. in press.

Espelin D. E. Done A. K. : Amphetamine Poisoning: Effectiveness of Chlorpromazine, N. Engl. J. Med. 278: 1361–1365, 1968.

Essig C. : Addiction to Non-barbiturates Sedatives and Tranquilizers, Clin. Pharmacol. Ther. 5: 334, 1964.

Forrest F. M. Forrest I. S. Serra M. T. : Modification of Chlorpromazine Metabolism by Some Other Drugs Frequently Administered to Psychiatric Patients, Bio. Psychiat. 2: 53–58, 1970.

Forrest W. H. Bellville J. W. Brown B. W. : The Interaction of Caffeine with Phenobarbital as a Nighttime Hypnotic, Anesthesiology 36: 37–41, 1972.

Fraser H. F. Isbell Harris Eisenmann A. J. Pescor F. T. : Chronic Barbiturate Intoxication, Arch. Intern. Med. 94: 21–41, 1954.

Fraser H. F. : Problems Resulting from the Use of Habituating Drugs in Industry, Amer. J. Pub. Health 48: 516, 1958.

Frey H. Kampman E. : Interaction of Amphetamine with Anticonvulsant Drugs. II. Effect of Amphetamine on the Absorption of Anticonvulsant Drugs, Acta Pharmacol. Toxicol. 24: 310–316, 1966.

Gardner R. : Methadone Misuse and Death by Overdosage, Brit. J. Addict. 65: 113–118, 1970.

Garrettson L. K. Perel J. M. Dayton P. G. : Methylphenidate Interaction with Both Anticonvulsants and Ethyl Biscoumacetate, J. Amer. Med. Assoc. 207: 2053–2056, March, 1969.

Garriott J. C. King L. J. Farney K. B. Hughes F. W. : Effects of Some Tetrahydrocannibinols on Hexobarbital Sleeping Time and Amphetamine-induced Hypoactivity in Mice, Life Sci. 6: 2119–2128, 1967.

Gokhale S. D. Gulati O. D. Udwadra B. P. : Antagonism of the Adrenergic Neuron Blocking Action of Guanethidine by Certain Antidepressants and Antihistamine Drugs, Arch. Int. Pharmacodyn. Ther. 160: 321–329, April, 1966.

Goldstein M. Anagnoste B. : The Conversion In Vivo of d-Amphetamine to (+)-p-Hydroxynorephedrine, Biochem. Biophys. Acta 107: 166–168, 1965.

Gong D. A. Rogers K. : Role of Brain Monoamines in the Fatal Hyperthermia Produced by Pethidine or Imipramine in Rabbits Pretreated with Pargyline, Brit. J. Pharmacol. 42: 646, 1972.

Greer W. F. Ireson J. D. : Pentobarbital Sleeping Time after Haloperidol and Promethazine, Arch. Internal Pharmacol. Ther. 196: 112–116, 1972.

Gruber C. M. Keyser G. F. : A Study of the Development of Tolerance and Cross Tolerance to Barbiturates in Experimental Animals, J. Pharmac. Exp. Ther. 86: 186, 1946.

Gulati O. D. Dave B. T. Gokhale S. D. Shah K. M. : Antagonism of Adrenergic Neuron Blockage in Hypertensive Subjects, Clin. Pharmac. Ther. 7: 510–514, 1966.

Hansten P. D. : Drug Interaction, Lea and Febiger Co., Philadelphia, Pa., 1971.

Heiser J. P. Gillin J. C. : The Reversal of Anticholinergic Drug-induced Delirium and Coma with Physostigmine, Amer. J. Psychiat. 127: 1050, 1971.

Hill H. F. Horita A. : Inhibition of t-Amphetamine Hyperthermia by Blockage of Dopamine Receptors in Rabbits, J. Pharm. Pharmacol. 23: 714–719, 1971.

Hill H. F. Horita A. : A Pimocide Sensitive Effect of Apomorphine on Body Temperature of the Rabbit, J. Pharm. Pharmacol. 24: 490–491, 1972.

Hollister L. E. Motzenbecker F. P. Vegan R. O. : Withdrawal Reactions from Chlordiazepoxide (Librium), Psychopharmacologia 2: 63–68, 1961.

Hollister L. E. Glazener F. S. : Withdrawal Reaction from Meprobamate, Alone and Combined with Promazine: A Controlled Study, Psychopharmocologia 1: 336, 1960.

Holtzman D. Lovell R. A. Jaffe J. H. Freedman D. X. : 1-Δ⁹-Tetrahydrocannabinol: Neurochemical and Behavioral Effects in the Mouse, Science 163: 1464–1467, 1969.

Hunningshake D. B. Azarnoff D. L. : Drug Interaction with Warfarin, Arch. Intern. Med. 121: 349–352, 1968.

Isbell H. : Addiction to Barbiturates and the Barbiturate Abstinence Syndrome, Ann. Intern. Med. 33: 108, 1950.

Jellinek P. : Dual Effects of d-Amphetamine on Body Temperature in the Rat, Eur. J. Pharmacol. 15: 389–392, 1971.

Johnson J. N. Gunne L. N. : Interaction of Fenfluramine with d-Amphetamine Induced Excitatory Behavior in Hypothermia, Eur. J. Pharmacol. 19: 52–55, 1972.

Johnson F. A. Von Buren H. C. : Abstinence Syndrome Following Glutethimide Intoxication, J. Amer. Med. Assoc. 180: 1024, 1962.

Jori A. Prestini P. E. Puglaliatti C. : Effects of Diazepam and Chlordiazepoxide in the Metabolism of Other Drugs, J. Pharm. Pharmacol. 21: 387–390, 1969.

Jounela A. J. Mattila M. J. : Modification by Phenelzine of Morphine and Pethidine Analgesia in Mice, Ann. Med. Exper. et Biol. Fenniae, 46: 66–71, 1968.

Jounela A. J. : “Effect of Phenelzine on the Rate of Metabolism of Pethidine.” Ann. Med. Exper. et Biol. Fenniae 46: 531–535, 1968.

Kabins S. A. : Interaction Among Antibiotics and Other Drugs, J. Amer. Med. Assoc. 219: 206–212, 1972.

Katmeir F. J. Spittell J. A. Jr. : Drug Interactions with Anticoagulants, Mayo Clin. Proc. 45: 249–255, 1970.

Kiplinger G. Manno J. E. Rodda B. E. Forney R. B. : Dose Response Analysis of the Effects of Tetrahydrocannabinol in Man, Clin. Pharmacol. Ther. 12: 650–657, 1971.

Kubena R. K. Barry H. III : Interactions of Δ¹-THC with Barbiturates and Methamphetamine, J. Pharmacol. Exp. Ther. 174: 94–100, 1970.

Kudrin A. N. Dangdona O. N. : Elimination of Hashish Intoxication with Phenitrone in Dogs, Farmako. J. Toksikol. 31: 549, 1968.

Kuenssberg E. V. : Side Effects of Ethchlorvynol, Brit. Med. J. 2: 1610, 1962.

Lee P. K. Cho M. H. Dobkin A. B. : Effects of Alcoholism, Morphinism, and Barbiturate Resistance on Induction and Maintenance of General Anesthesia, Can. Anesth. Soc. J. 11: 366–368, 1964.

Lemberger L. Witt E. Davis J. M. Kopin I. : The Effects of Haloperidol and Chlorpromazine on Amphetamine Metabolism and Amphetamine Stereotype Behavior in the Rat, J. Pharmacol. Exp. Ther. 174: 428–433, 1970a.

Lemberger L. Sernatinger E. Kuntzman R. : Effects of Desmethylimipramine, Iprindole and Erythro-α-3,4 dichlorophenyl-β-t-butylaminopropanol Hydrochloride on the Metabolism of Amphetamine, Biochem. Pharmacol. 19: 3021–3028, 1970b.

Lewis E. : Hyperpyrexia with Antidepressant Drugs, Brit. Med. J. 1: 1671–1672, 1965.

Lloyd J. T. Walker D. R. H. : Death After Combined Dexamphetamine and Phenezine, Brit. Med. J. 2: 168–169, 1965.

London D. R. Milne M. D. : Dangers of Monoamine Oxidase Inhibitors, Brit. Med. J. 2: 1752, 1962.

Lovelace A. H. Maxwell D. R. : A Comparison of the Effects of Imipramine, Trimapramine and Some Other Drugs in Rabbits Treated with Monoamine Oxidase Inhibitors, Brit. J. Pharmacol. 25: 158–170, 1965.

MacDonald M. G. Robinson D. S. Sylvester D. Jaffe J. J. : The Effects of Phenobarbital, Chloral Betaine, and Glutethimide Administered on Warfarin Plasma Levels and Hypoprothrombinemic Responses in Man, Clin. Pharmacol. Ther. 10: 80–84, 1968.

MacDonald R. : Tranylcypromine, Lancet 1: 269, 1963.

MacDonald M. G. Robinson D. S. : Clinical Observations of Possible Barbiturate Interference with Anticoagulation, J. Amer. Med. Assoc. 204: 97–100, 1968.

Mason A. : Fatal Reaction with Tranylcypromine with Methamphetamine, Lancet 1: 1073, 1962.

Matsumoto C. Griffin W. : Antagonism of +—amphetamine Induced Hyperthermia in Rats by Pimozide, J. Pharm. Pharmacol. 23: 710–715, 1971.

McCullough D. O. Milberg J. N. Robinson S. : A Central Site for the Hyperthermic Effect of Plus-Amphetamine Sulfate and p-Hydroxyamphetamine Hydrobromide in Mice, Brit. J. Pharmacol. 40: 219–226, 1970.

Mennear J. H. : Interaction Between Central Cholinergic Agents and Amphetamine, Psychopharmacologia 7: 107–111, 1965.

Milmon K. L. Morrelli H. F. Waddell R. J. Butler T. C. : The Distribution and the Excretion of Phenobarbital, J. Clin. Invest. 36: 1217–1226, 1957.

Milner G. : Interaction Between Barbiturates, Alcohol and Some Psychotropic Drugs, Med. J. Aust. 1: 1204–1207, 1970.

Mitchell R. S. : Fatal Toxic Encephalitis Occurring During Iproniazid Therapy in Pulmonary Tuberculosis, Ann. Intern. Med. 42: 417–419, 1955.

Morrison R. S. : Management of Emergency VIII: Metabolic Acidoses and Alkalosis, N. Engl. J. Med. 274: 1195–1196, 1966.

Morton R. C. Adriani J. : Drug Dependency—Important Considerations from the Anesthesiologist's Viewpoint, Anesth. Analg. 47: 472–481, 1968.

Murmann W. Almirante L. Saccuni-Fuelfi M. : Effects of Hexabarbitol, Ether, Morphine and Urethane Upon the Acute Toxicity of Propranolol and D-Inpea, J. Pharm. Pharmacol. 18: 692–695, 1966a.

Murmann W. Almirante L. Saccuni-Fuelfi M. : CNS Effects of 4 β-Adrenergic Receptor Blocking Agents, J. Pharm. Pharmacol. 18: 317–318, 1966b.

Nymark M. Nielsen J. M. : Reactions Due to the Combinations of Monoamine Oxidase Inhibitors with Thymoleptics, Pethidine and Methylamphetamine, Lancet 2: 524–525, 1963.

O'Really R. Aggler P. : Effects of Barbiturates on Oral Anticoagulants in Man, Clin. Res. 17: 153–156, 1969.

Pagnini G. Di Carlo R. Di Carlo F. Genazzani E. : Enhancement of Pentobarbital Narcosis by Drugs Competing on the Serum Protein Binding, Biochem. Pharmacol. 20: 3247–3254, 1971.

Palmer H. : Potentiation of Pethidine, Brit. Med. J. 2: 944, 1960.

Papp C. Benaim S. : Toxic Effects of Iproniazid in a Patient with Angina, Brit. Med. J. 2: 1070–1073, 1958.

Penn R. G. Rogers K. J. : Comparison of the Effects of Morphine, Pethidine and Pentazocine in Rabbits Pretreated with a Monoamine Oxidase Inhibitor, Brit. J. Pharmacol. 42: 485–492, 1971.

Pickett R. T. : Acute Toxicity of Heroin Alone and in Combination with Cocaine or Quinine, Brit. J. Pharmacol. 40: 145–146, 1970.

Reid N. C. R. W. Jones D. : Pethidine and Phenelzine, Brit. Med. J. 1: 408, 1962.

Reidt W. J. : Fatal Poisoning with Methyprylon (Nodular) A Non-Barbiturate Sedative, N. Engl. J. Med. 225: 231, 1956.

Rivers N. Horner B. : Possible Lethal Reaction Between Nardil and Dextromethorphan, Can. Med. Assoc. J. 103: 85, 1970.

Robinson D. MacDonald M. : The Effect of Phenobarbital Administration on the Control of Coagulation Achieved During Warfarin Therapy in Man, J. Pharmacol. Exp. Ther. 153: 250–253, 1966.

Rogers G. A. : Addiction to Glutethimide (Doriden), Amer. J. Psychiat. 115: 551, 1958.

Rogers K. J. : Role of Brain Monoamines in the Interaction Between Pethidine and Tranylcypromine, Eur. J. Pharmacol. 14: 86–88, 1971.

Rosenblatt J. E. Janowsky D. S. Davis J. M. El-Yousef M. K. : The Augmentation of Physostigmine Toxicity in the Rat by Δ⁹-Tetrahydrocannabinol, Res. Commun. Chem. Pathol. Pharmacol. 3: 479–482, 1972.

Rowland M. Beckett A. H. : The Amphetamine: Clinical and Pharmaco-kinetic Implications of Recent Studies of an Assay Procedure and Urinary Excretion in Man, Arzneim. Forschung 16: 1369–1372, 1966.

Sellars E. M. Koch-Weser J. : Potentiation of Warfarin-induced Hypoprothrombinemia by Chloral Hydrate, N. Engl. J. Med. 283: 827–831, 1970.

Shah H. C. Harbans L. : The Potentiation of Barbiturates by Desipramine in the Mouse: Mechanism of Action, J. Pharmacol. Exp. Ther. 179: 404–409, 1971.

Shee J. : Dangerous Potentiation of Pethidine by Iproniazid and Its Treatment, Brit. Med. J. 2: 507–591, 1960.

Sher S. : Drug Enzyme Induction and Drug Interactions, Literature Tabulation, Toxicol. Appl. Pharmacol. 18: 780–834, 1971.

Sherman M. Hauser G. C. Glover B. H. : Toxic Reaction to Tranylcypromine, Amer. J. Psychiat. 120: 1019–1021, 1964.

Sigell L. T. Flessa H. C. : Drug Interactions with Anticoagulants, J. Amer. Med. Assoc. 214: 2035–2038, 1970.

Sinclair J. R. : The Effects of Pethidine and Morphine in Rabbits Treated with Phenelzine, Toxicol. Appl. Pharmacol. 22: 231–240, 1972.

Sjoerdsma A. Von Studnitz W. : Dopamine-β-oxidase Activity in Man Using Hydroxyamphetamine as a Substrate, Brit. J. Pharmacol. 20: 278–283, 1963.

Smith B. E. Pino T. R. : Glutethimide Therapy and Overdosage. A Review with Reports of a Case, U. Armed Forces Med. J. 11: 161–166, 1960.

Solomine H. J. Abrams W. B. : Interaction Between Digitoxin and Other Drugs, Amer. Heart J. 83: 277–80, 1972.

Spaulding T. Ford R. P. Dewey W. L. McMillan D. E. Harris L. S. : Some Pharmacological Effects of Phenitrone and Its Interaction with Δ⁹-THC, Eur. J. Pharmacol. 19: 310–317, 1972.

Stark D. : Effects of Giving Vasopressors to Patients on Monoamine Oxidase Inhibitors, Lancet 2: 1405, 1962.

Sulser F. Dingell J. V. : The Potentiation and Blockage of the Central Action of Amphetamine by Chlorpromazine, Can. Physiol. Pharmacol. 47: 7–13, 1969.

Sulser F. Owens M. L. Dingell J. V. : On the Mechanism of Amphetamine Potentiation by Desipramine (DMI), Life Sci. 5: 2005–2010, 1966.

Taylor D. C. : Alarming Reaction to Pethidine in Patients on Phenelzine, Lancet 2: 401–402, 1962.

Thoenen H. Hurlimann K. F. Gey K. F. Haefely W. : Liberations of p-Hydroxynorephedrine from Cat Spleen by Sympathetic Nerve Stimulation after Pretreatment with Amphetamine, Life Sci. 5: 1715–1722, 1966.

Tonks C. M. Livingston D. : Monoamine Oxidase Inhibitors, Lancet 1: 1223–1224, 1963.

Valzelli L. L. Consolo S. Morpurgo C. : Influence of Impramine-like Drugs on the Metabolism of the Amphetamines, in: Garrattini S. , ed. Antidepressant Drugs. Experta Medica Press, Milan, Italy, 1966.

Van Dam F. E. Overkemp M. Haansen C. : The Interaction of Drugs, Lancet 2: 1027, 1966.

Vigran J. M. : Dangerous Potentiation of Meperidene HO by Pargylene HO, J. Amer. Med. Assoc. 187: 953–954, 1964.

Welch B. : Rapid Depletion of Adrenal Epinephrine and Elevation of Telenephalic Serotonin by Trans Δ⁹ Tetrahydrocannabinol in Mice, Res. Commun. Chem. Pathol. Pharmacol. 2: 302, 1971.

Zeck P. : Dangers of Some Antidepressant Drugs, Med. J. Aust. 2: 607–608, 1961.

Zivin I. Shalowitz M. : Acute Toxic Reaction and Prolonged Glutethimide Administration, N. Engl. J. Med. 266: 496–498, 1962.